European Journal of Pediatrics

, Volume 150, Issue 5, pp 374–378 | Cite as

Haemostatic measurements in childhood nephrotic syndrome

  • A. T. H. Elidrissy
  • M. B. Abdurrahman
  • H. M. Bahakim
  • M. D. Jones
  • A. M. A. Gader


Blood coagulation and platelet aggregation were assessed in children, with nephrotic syndrome who were divided into the following groups: (1) relapse without treatment; (2) relapse on steroids; (3) early remission; (4) late remission and (5) steroid resistant. The renal histological findings were also recorded. Plasma antithrombin III (ATIII) levels were markedly reduced in groups 1 and 2, below normal in group 3 and were normal in groups 4 and 5. There was significant urinary loss of AT III in groups 1 and 2 as well as in group 5. Plasma fibrinogen fluctuations exhibited the expected negative correlations with plasma AT III. Reptilase time showed significant prolongation in groups 1, 2 and 3, and was near normal in groups 4 and 5. Platelet aggregation in response to arachidonic acid exhibited aggregation followed by disaggregation in groups 1, 2, 4 and 5, and was normal in group 3. Hyperaggregation in response to decreasing doses of ADP was noted in all patient groups as well as controls with no relationship to serum albumin levels. Aggregation responses to collagen and ristocetin were normal. It is concluded that: 1. The fluctuations in AT III levels in childhood nephrotic syndrome are determined by the response to steroids and not by the renal histology per se. 2. An acquired fibrin polymerization defect (dysfibrinogenaemia) and an abnormality of the prostaglandin pathway of platelet activation, both reversible, are yet other haemostatic abnormalities in childhood nephrosis. 3. The discrepancies in the literature on haemostatic parameters, specially AT III in childhood nephrosis, would not have arisen if their fluctuation in relation to steroid therapy as well as the renal histological features of nephrotic syndrome had been documented simultaneously.

Key words

Nephrotic syndrome AT III Fibrinogen Platelet aggregation Reptilase time 



Antithrombin III


Focal segmental glomerulosclerosis


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alkjaersig N, Fletcher AP, Narayanan M, Robson AM (1987) Course and resolution of the coagulopathy in nephrotic children. Kidney Int 31:772–780Google Scholar
  2. 2.
    Andrassy K, Ritz E, Bommer J (1980) Hypercoagulability in the nephrotic syndrome. Klin Wochenschr 58:1029–1036Google Scholar
  3. 3.
    Andren L, Wadenvik H, Kutti J, Hansson L (1983) Stress and platelet activation. Acta Haematol 70:302–306Google Scholar
  4. 4.
    Babiker MA, Ashong EF, Bahakim H, Gader AMA (1987) Coagulation changes in sickle cell disease in early childhood. Acta Haematol 77:156–160Google Scholar
  5. 5.
    Bennett A, Cameron JS (1987) Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration. Clin Nephrol 27:182–188Google Scholar
  6. 6.
    Born GVR, Mills DCB, Roberts GCK (1967) Potentiation of platelet aggregation by adrenaline. J Physiol 191:43p-44pGoogle Scholar
  7. 7.
    Elidrissy ATH, Gader AMA (1985) Antithrombin III (AT III) and fibrinogen levels in neprotic syndrome in children. Haemostasis 15:384–388Google Scholar
  8. 8.
    Flute PT (1979) Disorders of plasma fibrinogen synthesis. Br Med Bull 33:253–259Google Scholar
  9. 9.
    Gader AMA, Bahakim H, Jabbar FA, Lambourne AL, Gaafar TH, Edrees YB (1988) Dose-response aggregometry in maternal/neonatal platelets. Thromb Haemost 60:314–318Google Scholar
  10. 10.
    Hoyer PF, Gonda S, Barthels M, Krohn P, Brodehl J (1986) Thromboembolic complications in children with nephrotic syndrome. Acta Paediatr Scand 75:804–810Google Scholar
  11. 11.
    Jackson CA, Greaves M, Patterson AD, Brown CB, Preston FE (1982) Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. Br J Haematol 52:69–77Google Scholar
  12. 12.
    Jorgensen KA, Stoffersen E (1979) Antihrombin, III and the nephrotic syndrome. Scand J Haematol 22:442–448Google Scholar
  13. 13.
    Kauffman A, Veltkamp J, Tiberg N, Van EL (1978) Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 65:607–613Google Scholar
  14. 14.
    Kendall AG, Lohmann RE, Dossetor JB (1971) Nephrotic syndrome: a hypercoagulable state. Arch Intern Med 127: 1021–1027Google Scholar
  15. 15.
    Llach R (1982) Nephrotic syndrome: hypercoagulability, renal vein thrombosis and other thromembolic complications. In: Brenner BM, Stein JH (eds) Nephrotic syndrome. Churchill Livingstone, Edinburgh, pp 121–144Google Scholar
  16. 16.
    Mehls O, Andrassy K, Koderisch J, Herzog U, Ritz E (1987) Hemostasis and thromboembolism in children with nephrotic syndrome: Differences from adults. J Paediatr 110:862–867Google Scholar
  17. 17.
    Panicucci F, Sagripanti A, Vispi M, Pinori E, Lecchini L, Barsotti G, Giovannetti S (1983) Comprehensive study of haemostasis in nephrotic syndrome. Nephron 33:9–13Google Scholar
  18. 18.
    Remuzzi G, Mecca G, Marchesi D, Livio M, Gaetano GD, Donati MB, Silver MJ (1979) Platelet hyperaggregability and the nephrotic syndrome. Thromb Res 16:345–354Google Scholar
  19. 19.
    Samama M, Soria J, Soria C (1977) Congenital and acquired dysfibrinogenaemia. In: Poller L (ed) Recent advances in blood coagulation. Churchill Livingstone, Edinburgh, pp 313–335Google Scholar
  20. 20.
    Stuart MJ, Spitzer RE, Nelson DA, Sills RH (1980) Nephrotic syndrome: increased platelet prostaglandin endoperoxide formation, hyperaggregability, and reduced platelet life span. Reversal following remission. Pediatr Res 14:1078–1081Google Scholar
  21. 21.
    Thaler E, Blazar E, Kopsa H, Pinggera W (1978) Acquired antithrombin III deficiency in patients with glomerular proteinura. Haemostasis 7:257–272Google Scholar
  22. 22.
    Ueda N, Kawaguchi S, Niinomi Y, Nonoda T, Matsumoto J, Onishi M, Yasaki T (1987) Effect of corticosteroids on coagulation factors in children with nephrotic syndrome. Pediatr Nephrol 1:286–289Google Scholar
  23. 23.
    Vaziri ND, Paule P, Toohey J, Hung E, Alikhani, Darwish R, Pahl MV (1984) Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Intern Med 144: 1802–1803Google Scholar
  24. 24.
    Walter E, Deppermann D, Andrassy K, Koderisch J (1981) Platelet hyperaggregability as a consequence of the nephrotic syndrome. Thromb Res 23:473–479Google Scholar
  25. 25.
    Yoshida N, Aoki N (1978) Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome. Blood 52:969–977Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • A. T. H. Elidrissy
    • 1
  • M. B. Abdurrahman
    • 1
  • H. M. Bahakim
    • 1
  • M. D. Jones
    • 2
  • A. M. A. Gader
    • 2
  1. 1.Department of PaediatricsCollege of Medicine and King Khalid University HospitalRiyadSaudi Arabia
  2. 2.Department of PhysiologyCollege of Medicine and King Khalid University HospitalRiyadSaudi Arabia

Personalised recommendations